Nora Isberner
Impact in
-
- Chronic Lymphocytic Leukemia Research
-
- Chronic Myeloid Leukemia Treatments
- Hematopoietic Stem Cell Transplantation
Papers in
-
- COVID-19 Clinical Research Studies 4
- Genetics 4
- Chronic Lymphocytic Leukemia Research 3
- Virus-based gene therapy research 1
- Co-authors
- Hartwig Klinker (9 shared papers)Oliver Scherf‐Clavel (7 shared papers)Max Kurlbaum (6 shared papers)Götz Ulrich Grigoleit (6 shared papers)Sabrina Kraus (6 shared papers)Theo Pelzer (3 shared papers)Bastian Schilling (3 shared papers)Charis Kalogirou (3 shared papers)
In The Last Decade
Nora Isberner
13 papers receiving 147 citations
Peers
Comparison fields: 5 of 44
- Genetics 18
- Hematology 19
- Infectious Diseases 29
- Immunology 33
- Transplantation 3
Countries citing papers authored by Nora Isberner
This map shows the geographic impact of Nora Isberner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nora Isberner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nora Isberner more than expected).
Fields of papers citing papers by Nora Isberner
This network shows the impact of papers produced by Nora Isberner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nora Isberner. The network helps show where Nora Isberner may publish in the future.
Co-authors
The 25 scholars most cited alongside Nora Isberner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 35 | |
| 2 | 2022 | 25 | |
| 3 | 2021 | 12 | |
| 4 | 2021 | 12 | |
| 5 | 2023 | 12 | |
| 6 | 2021 | 10 | |
| 7 | 2022 | 9 | |
| 8 | 2022 | 8 | |
| 9 | 2020 | 7 | |
| 10 | 2022 | 5 | |
| 11 | 2021 | 4 | |
| 12 | 2022 | 4 | |
| 13 | 2020 | 4 | |
| 14 | COVID-19 in cancer patients: Clinical characteristics and outcome - a first analysis of the LEOSS registry | 2020 | 0 |
About Nora Isberner
Nora Isberner is a scholar working on Infectious Diseases, Genetics, Oncology, Molecular Biology and Epidemiology, having authored 14 papers that have together received 147 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (4 papers), Chronic Lymphocytic Leukemia Research (3 papers), Chronic Myeloid Leukemia Treatments (2 papers), Cytomegalovirus and herpesvirus research (2 papers), Biosimilars and Bioanalytical Methods (2 papers), CAR-T cell therapy research (2 papers), Hermeneutics and Narrative Identity (1 paper) and Virus-based gene therapy research (1 paper). The work is most often cited by research in Genetics (18 citations), Hematology (19 citations), Infectious Diseases (29 citations), Immunology (33 citations) and Transplantation (3 citations). Nora Isberner has collaborated with scholars based in Germany, China and France. Frequent co-authors include Hartwig Klinker, Oliver Scherf‐Clavel, Max Kurlbaum, Götz Ulrich Grigoleit, Sabrina Kraus, Theo Pelzer, Bastian Schilling, Charis Kalogirou, Maria-Elisabeth Goebeler and Siegbert Rieg. Their work appears in journals such as Journal of Pharmaceutical and Biomedical Analysis, Pharmaceutics, Infection, Cancers and Journal of Chromatography B.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.